| Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas CJ Wikstrand, LP Hale, SK Batra, ML Hill, PA Humphrey, SN Kurpad, ... Cancer research 55 (14), 3140-3148, 1995 | 653 | 1995 |
| Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. PA Humphrey, AJ Wong, B Vogelstein, MR Zalutsky, GN Fuller, GE Archer, ... Proceedings of the National Academy of Sciences 87 (11), 4207-4211, 1990 | 479 | 1990 |
| Clinical experience with α-particle–emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6 MR Zalutsky, DA Reardon, G Akabani, RE Coleman, AH Friedman, ... Journal of Nuclear Medicine 49 (1), 30-38, 2008 | 452 | 2008 |
| Pinhole collimation for ultra-high-resolution, small-field-of-view SPECT RJ Jaszczak, J Li, H Wang, MR Zalutsky, RE Coleman Physics in Medicine & Biology 39 (3), 425, 1994 | 388 | 1994 |
| Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia DE Meyer, GA Kong, MW Dewhirst, MR Zalutsky, A Chilkoti Cancer research 61 (4), 1548-1554, 2001 | 363 | 2001 |
| Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly … DA Reardon, G Akabani, R Edward Coleman, AH Friedman, HS Friedman, ... Journal of Clinical Oncology 20 (5), 1389-1397, 2002 | 332 | 2002 |
| A plasmonic gold nanostar theranostic probe for in vivo tumor imaging and photothermal therapy Y Liu, JR Ashton, EJ Moding, H Yuan, JK Register, AM Fales, J Choi, ... Theranostics 5 (9), 946, 2015 | 314 | 2015 |
| Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the … JH Sampson, G Akabani, GE Archer, DD Bigner, MS Berger, AH Friedman, ... Journal of neuro-oncology 65, 27-35, 2003 | 293 | 2003 |
| Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody D Colcher, M Zalutsky, W Kaplan, D Kufe, F Austin, J Schlom Cancer research 43 (2), 736-742, 1983 | 287 | 1983 |
| Astatine-211-labeled radiotherapeutics an emerging approach to targeted alpha-particle radiotherapy MR Zalutsky, G Vaidyanathan Current pharmaceutical design 6 (14), 1433-1455, 2000 | 269 | 2000 |
| The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target CJ Wikstrand, CJ Reist, GE Archer, MR Zalutsky, DD Bigner Journal of neurovirology 4 (2), 148-158, 1998 | 254 | 1998 |
| A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine MR Zalutsky, AS Narula International Journal of Radiation Applications and Instrumentation. Part A …, 1987 | 243 | 1987 |
| Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. DD Bigner, MT Brown, AH Friedman, RE Coleman, G Akabani, ... Journal of clinical oncology 16 (6), 2202-2212, 1998 | 238 | 1998 |
| A thermally responsive biopolymer for intra-articular drug delivery H Betre, W Liu, MR Zalutsky, A Chilkoti, VB Kraus, LA Setton Journal of controlled release 115 (2), 175-182, 2006 | 235 | 2006 |
| Salvage radioimmunotherapy with murine iodine-131–labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase … DA Reardon, G Akabani, RE Coleman, AH Friedman, HS Friedman, ... Journal of clinical oncology 24 (1), 115-122, 2006 | 232 | 2006 |
| In situ growth of a stoichiometric PEG-like conjugate at a protein's N-terminus with significantly improved pharmacokinetics W Gao, W Liu, JA Mackay, MR Zalutsky, EJ Toone, A Chilkoti Proceedings of the National Academy of Sciences 106 (36), 15231-15236, 2009 | 221 | 2009 |
| Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors JH Sampson, G Akabani, GE Archer, MS Berger, RE Coleman, ... Neuro-oncology 10 (3), 320-329, 2008 | 221 | 2008 |
| Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α-, β-, and Auger electron–emitting radionuclides M Boyd, SC Ross, J Dorrens, NE Fullerton, KW Tan, MR Zalutsky, ... Journal of nuclear medicine 47 (6), 1007-1015, 2006 | 210 | 2006 |
| Astatine-211: production and availability M R Zalutsky, M Pruszynski Current radiopharmaceuticals 4 (3), 177-185, 2011 | 209 | 2011 |
| Copper signaling axis as a target for prostate cancer therapeutics R Safi, ER Nelson, SK Chitneni, KJ Franz, DJ George, MR Zalutsky, ... Cancer research 74 (20), 5819-5831, 2014 | 193 | 2014 |
Ganesan VaidyanathanDuke University Medical CenterAdresse e-mail validée de duke.edu